🇺🇸 FDA
Patent

US 11858930

Fused bicyclic RAF inhibitors and methods for use thereof

granted A61KA61K45/06A61P

Quick answer

US patent 11858930 (Fused bicyclic RAF inhibitors and methods for use thereof) held by Jazz Pharmaceuticals Ireland Limited expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K45/06, A61P, A61P35/00